Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer

De novo metastatic or recurrence of prostate cancer (PC) remains life-threatening. Circulating tumor cells (CTCs) are noninvasive biomarkers and provide unique information that could enable tailored treatment. This study evaluated the impact of CTCs in PC patients eligible for peptide vaccine therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Guldvik, Ingrid Jenny, Ekseth, Lina, Kishan, Amar U., Stensvold, Andreas, Inderberg, Else Marit, Lilleby, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303369/
https://www.ncbi.nlm.nih.gov/pubmed/34206815
http://dx.doi.org/10.3390/jpm11070605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303369/
https://www.ncbi.nlm.nih.gov/pubmed/34206815
http://dx.doi.org/10.3390/jpm11070605

Ejemplares similares